Vitalhub (TSE:VHI)
TSX:VHI
Want to see TSE:VHI full AI Analyst Report?
VHI Stock Chart & Stats
C$7.91
-C$0.14(-1.23%)
At close: 4:00 PM EST
C$7.91
-C$0.14(-1.23%)
Day’s Range― - ―
52-Week RangeC$6.67 - C$14.64
Previous CloseN/A
Volume94.87K
Average Volume (3M)148.97K
Market Cap
C$507.12M
Enterprise ValueC$457.06M
Total Cash (Recent Filing)C$119.18M
Total Debt (Recent Filing)C$2.51M
Price to Earnings (P/E)90.7
Beta0.72
Next Earnings
May 07, 2026EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding63,232,063
10 Day Avg. Volume164,389
30 Day Avg. Volume148,972
Financial Highlights & Ratios
PEG Ratio1.42
Price to Book (P/B)2.08
Price to Sales (P/S)5.09
P/FCF Ratio70.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$12.60Price Target Upside59.29% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)0.29
Revenue Forecast (FY)C$130.08M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetExtremely low leverage (debt-to-equity ~0.9% in 2025) materially lowers financial risk and gives management durable flexibility to fund growth, pursue acquisitions, or withstand downturns without reliance on external debt, supporting stability over the next 2–6 months.
Consistent Revenue Growth And Profit ShiftA multiyear pattern of strong revenue growth and a structural shift from prior losses to sustained profitability indicates product-market fit and recurring demand from healthcare customers, underpinning predictable revenue and margin improvement prospects over the medium term.
Strong Cash Conversion AlignmentFree cash flow nearly matches net income (FCF/net income ~0.95), signaling that reported profits largely convert to cash. This durable cash conversion capacity supports reinvestment, working capital needs, and optionality for capital allocation without depending on raising debt.
Bears Say
Modest, Volatile MarginsRelatively low and variable margins, with a stepped-down gross margin in 2025, indicate limited pricing power or rising unit costs. Over months this constrains the ability to scale profits from revenue growth and makes earnings sensitive to cost or contract pressures in public-sector healthcare customers.
Weakened Cash Flow MomentumA sharp ~35% FCF decline and lower operating cash flow versus prior year reduce near-term financial flexibility despite low leverage. This deterioration can constrain investments and increase sensitivity to operational hiccups, undermining durable capacity to self-fund growth.
Low Returns On EquityROE near 2.3% signals that equity growth has not translated into strong shareholder returns. Persistently low ROE suggests inefficient capital deployment or early-stage profitability scaling challenges, limiting the long-term upside for investors despite revenue expansion.
Vitalhub News
VHI FAQ
What was Vitalhub’s price range in the past 12 months?
Vitalhub lowest stock price was C$6.67 and its highest was C$14.64 in the past 12 months.
What is Vitalhub’s market cap?
Vitalhub’s market cap is C$507.12M.
When is Vitalhub’s upcoming earnings report date?
Vitalhub’s upcoming earnings report date is May 07, 2026 which is in 6 days.
How were Vitalhub’s earnings last quarter?
Vitalhub released its earnings results on Mar 18, 2026. The company reported C$0.06 earnings per share for the quarter, beating the consensus estimate of C$0.026 by C$0.034.
Is Vitalhub overvalued?
According to Wall Street analysts Vitalhub’s price is currently Undervalued.
Does Vitalhub pay dividends?
Vitalhub does not currently pay dividends.
What is Vitalhub’s EPS estimate?
Vitalhub’s EPS estimate is 0.06.
How many shares outstanding does Vitalhub have?
Vitalhub has 63,232,063 shares outstanding.
What happened to Vitalhub’s price movement after its last earnings report?
Vitalhub reported an EPS of C$0.06 in its last earnings report, beating expectations of C$0.026. Following the earnings report the stock price went down -9.209%.
Which hedge fund is a major shareholder of Vitalhub?
Currently, no hedge funds are holding shares in TSE:VHI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vitalhub Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$12.60 (59.29% Upside)
C$12.60 (59.29% Upside)
Blogger Sentiment
Bullish
TSE:VHI Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth C$3.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 0.6%
Last 30 Days ▼ 0.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
7.33%
12-Months-Change
Fundamentals
Return on Equity
2.75%
Trailing 12-Months
Asset Growth
70.24%
Trailing 12-Months
Company Description
Vitalhub
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination, patient flow and operational visibility, and mobile apps. The company was incorporated in 2010 and is based in Toronto, Canada.
VHI Stock 12 Month Forecast
Average Price Target
C$12.60
▲(59.29% Upside)
Technical Analysis
Diagnos
―
kneat.com
―
nDatalyze Corp
―
Comprehensive Healthcare Systems Inc
―
UniDoc Health Corp
―
Options Prices
Currently, No data available
---